Home | News | The Spanish association of local governments and the first ‘CNIO Friend’ town hall visit CNIO

The Spanish association of local governments and the first ‘CNIO Friend’ town hall visit CNIO


Research needs you

From left to right: Carlos Daniel Casares, Maria Blasco and José Ruiz. /Laura Lombardía. CNIO

The Spanish Federation of Municipalities and Provinces (FEMP) and CNIO will explore how to collaborate at an institutional level

They would like to create a network of towns willing to become CNIO Friends

“We have seen the hardest side of cancer, but we have also seen the friendly side of cancer being cured. To always see the latest we have to trust research”. With these words pronounced on the last World Cancer Research Day, Mayor José Ruiz explained the reason why his town Torreperogil (Jaen) has become the first in Spain which belongs to the CNIO Friends association.

His speech bore an idea: the creation of a network of CNIO Friends city halls, a community of towns willing to contribute philanthropically to cancer research.

This and other ideas aimed at establishing a collaboration among institutions were dicussed at the meeting held by Carlos Daniel Casares, of the Spanish Federation of Municipalities and Provinces (FEMP), José Ruiz and CNIO Director Maria A. Blasco.

FEMP brings together most city halls and provincial councils of Spain, up to 7,410 local entities representing more than 95% of the local Governments in the country. FEMP is also the Spanish section of the Council of European Municipalities and Regions (CMRE in Spanish), as well as the official headquarters of the Ibero-American Organization for Intermunicipal Cooperation (OICI).

During the meeting, Carlos Daniel Casares stressed the need of “raising public awareness on cancer research”, a task that also falls to local Governments.

Thanks to the Torreperogil contribution, together with that of other CNIO Friends, the CNIO hires outstanding young researchers and open new lines of research with which to understand, diagnose and tackle cancer effectively.

Back to the news